Think Before You Make a RAS Decision: Evaluating the Use of RAS Blockers in Patients with Diabetes

February 24, 2017

Hypertension affects more than 70% of patients with type 2 diabetes mellitus and further increases the risk of cardiovascular disease in this high-risk population. While renin angiotensin system (RAS) blockers are clearly indicated in patients with heart failure, chronic kidney disease with proteinuria, and coronary artery disease (CAD), experts have come to different conclusions regarding their role as initial antihypertensive therapy for patients with diabetes.

Theme Music by Good Talk

00:0000:00

Facebook Comments: